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Summary
The main remit of the European Society for Paediatric Anaesthesiology (ESPA) Pain
Committee is to improve the quality of pain management in children. The ESPA Pain
Management Ladder is a clinical practice advisory based upon expert consensus to
help to ensure a basic standard of perioperative pain management for all children.
Further steps are suggested to improve pain management once a basic standard has
been achieved. The guidance is grouped by the type of surgical procedure and lay-
ered to suggest basic, intermediate, and advanced pain management methods. The
committee members are aware that there are marked differences in financial and
personal resources in different institutions and countries and also considerable vari-
ations in the availability of analgesic drugs across Europe. We recommend that the
guidance should be used as a framework to guide best practice.
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1 | INTRODUCTION
Adequate pain therapy cannot be taken for granted. Although the
Declaration of Montreal (September 2010) states that “Access to
Pain Management is a Fundamental Right”, it is estimated that 80%
of the global population is affected by insufficient pain management,
and this is a serious problem in over 150 countries.1,2 The greatest
burden of inadequate pain management is carried by the elderly,
pregnant, and breastfeeding women, children, drug addicted persons,
and the mentally ill.3 For many years there have been increasing
efforts to improve the perioperative pain management of children
but there are still a substantial number of children suffering periop-
erative pain.4-10
The practice of pediatric anesthesia varies considerably across
Europe, including the provision of postoperative analgesia, as evi-
denced by the results of the recent Anaesthesia PRactice In Children
Observational Trial (APRICOT).11 The reasons are multifactorial but
may reflect differences in knowledge, infrastructure, organization,
and health care economics among EU countries. However, even in
more affluent settings, pediatric postoperative pain management is
highly variable and is still suboptimal in many centers.12
Against this background, it is important to define the minimum
standards of pediatric postoperative pain relief that children can
expect after surgical procedures even in settings with limited
resources. It is also important to outline how pediatric postoperative
pain relief may evolve and improve. This ESPA supported document
may enable clinicians and departments to influence decision-making
to improve and advance pediatric postoperative pain relief regardless
of the local context since adherence to suggested guidelines has
been shown to be helpful in improving pain management, eg, for
pediatric tonsillectomy.13
Thus, the aim of the current ESPA initiative is to provide a con-
sensus practice advisory document analogous to the WHO Pain
Relief Ladder,14 based pragmatically upon existing evidence and
already published guidelines, to improve pediatric postoperative
pain relief in Europe. Although primarily aimed at the European
continent, we hope that it may also be applied in other countries
around the world.
2 | MATERIALS AND METHODS
The ESPA Pain Committee selected 6 common pediatric surgical pro-
cedures and invited pediatric anesthetists experienced in treating
postoperative pain from different countries to participate in working
groups to develop 1 pain management ladder each aiming for a mul-
timodal analgesic treatment approach15,16 based upon the WHO
Pain Relief Ladder including local and regional anesthetic techniques.
In the first step, each member of a particular pain ladder group was
invited to provide the individual pain management of his/her institu-
tion to collate the most common pain management concepts and
drugs used for each type of operation. Following this, the concepts
were discussed by the working group and the literature was
reviewed, including existing evidence-based guidelines. The ESPA
Pain Management Ladder is a clinical practice advisory based upon
the consensus opinions of these working groups. As a result, a basic
acceptable level of pain management was suggested which should
be achievable by all, even in institutions with limited resources. Oral
and rectal administration of nonopioid drugs and regional anesthesia
play a crucial role since they are available in most places.17-21 Good
use of these modalities has an important opioid-sparing effect.7,8,15,22
Intravenous opioids are reserved for intraoperative use and the early
postoperative period in settings with adequate monitoring. Further-
more, in all procedures where endotracheal intubation is essential,
the administration of a small dose of a short-acting opioid may be
considered in order to attenuate the hemodynamic response to
laryngoscopy and tracheal intubation,23,24 albeit at the expense of
the possibility of increased postoperative nausea and vomiting.
Subanesthetic doses of ketamine/S-ketamine may be used to reduce
intra- and early postoperative opioid requirements.25,26
3 | HOW TO USE THE ESPA PAIN
MANAGEMENT LADDER
Before an institution considers changes in pain management, it has
to be decided if there is a need for change.27 Therefore, the first
step would be to evaluate the current pain management for a certain
type of operation. The drugs used and whether doses prescribed are
actually administered are useful baseline assessments. It is strongly
suggested that standardized pain assessment for the duration of hos-
pital stay should be used, preferably with validated age-appropriate
pain assessment tools.28-34 Useful audit markers are the proportion
of each patient’s time spent with pain scores below 4/10 and child
and family experiences of pain. If a lack of adequate pain manage-
ment is revealed, a plan to improve the pain management and evalu-
ate this improvement will be needed.35,36 Considering pain as a vital
sign is an excellent way to engender change, with incorporation of
pain assessment into charts, nursing routines, and education pro-
grams. This must include an algorithm showing what actions to take
when a pain score is high and how to evaluate the efficacy of any
analgesic interventions.34
The primary aim is to attain at least the basic level of the ESPA
Pain Management Ladder. Since the basic level uses drugs and meth-
ods that are widely available, are proven to work, are safe, and do
not require any complex monitoring, the major change initially
required to achieve successful pain management is education, not
new drugs or high-tech delivery systems. Basic techniques can do
the job in a high proportion of cases if physicians and nurses are
trained to take responsibility for providing pain control37 and all staff
dealing with children give pain assessment and pain management a
high priority.
The secondary goal is to climb up the pain ladder as far as possi-
ble using all available resources. The intermediate and advanced
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levels should be considered as suggestions. These steps represent a
gradual increase in complexity and require specific equipment and
infrastructure. Analgesia may be improved: for example, a substantial
improvement of success rate when using ultrasound-guided ilioin-
guinal/iliohypogastric nerve block instead of a landmark-based tech-
nique; using intravenous paracetamol greatly increases the likelihood
of having adequate plasma levels of paracetamol in the recovery
room.38-40
The ESPA Pain Management Ladder may help to provide practi-
tioners with a document to present to their local officials with the
aim of promoting and improving postoperative analgesia for the
pediatric population (Table 1). Surgical colleagues and hospital
administrators should be aware that acceptable standards of pain
management have to be provided and resourced before surgery in
infants and children is undertaken.41 The ability of structured initia-
tives to substantially improve postoperative analgesia in resource
limited settings has recently been presented by Dr Burke (Tygerberg
Children’s Hospital, South Africa)42 as well after day surgery in more
affluent circumstances.43
The aim is to develop a pediatric pain management portfolio that
can be adapted for local use based upon availability of drugs,
national recommendations, and drug registration rules in different
countries. The target should be to achieve and maintain pain scores
below the intervention threshold of 4 (on a 10-point scale). Pain
TABLE 1 Quality improvement steps using the ESPA Pain Ladder
Procedure Goal
Step 1 Written individualized standard
prescription for current pain management
for the procedure
Exact prescription and administration of analgesics prescribed for each patient
to improve pain management
Step 2 Pain assessment: at least 3 times per day
until discharge to check pain experience
and efficacy of analgesia.
Consider pain as a vital sign.
Makes pain visible by use of appropriate assessments.
If inadequate pain management is revealed, improve the pain management
regimen and culture
Step 3 Improve pain management education and
delivery of at least basic level of ESPA
Pain Ladder.
Ensure analgesics are given as prescribed.
Ensure pain is assessed regularly
Ensure pain score is <4/10 for as much time as possible
Step 4 Re-evaluate to check for improvements Further adaptation of management if necessary
Step 5 Introduce intermediate and advanced
levels as appropriate to local needs and
circumstances
Ensure efficacy and safety by comprehensive education, staffing, and monitoring
Example of improvement of pain management for Inguinal Hernia Repair
Problem Improvement step
Step 1 The lack of institutional agreement about
how pain management should be
performed has led to individual
interpretation and management with
variable efficacy.
No prescription for breakthrough pain in
PACU (nurse has to call physician)
Multidisciplinary agreement with written institutional instruction using techniques in
basic level of ESPA Pain Ladder
Intraoperative pain management: rectal NSAID or if not available rectal paracetamol
(loading dose). Local anesthetic infiltration by the surgeon,
Postoperative management: Oral NSAIDs and/or paracetamol in adequate dosing on
demand or preferably timed by the clock
Step 2 Missing or irregular pain assessment Regular pain assessment demonstrates inadequate pain management (prolonged
breakthrough pain in PACU and frequent high pain scores in the ward) and proves
the need for improvement of the pain management regimen
Step 3 Inadequate pain management Adaptation of pain management—new standard prescription order:
Intraoperative pain management: Rectal NSAID or if not available rectal paracetamol
(loading dose)
Local wound infiltration by the surgeon of a long-acting local anesthetic.
Postoperative management: Intravenous fentanyl or morphine to treat breakthrough pain
in the PACU.
Oral NSAIDs and/or paracetamol in adequate dosing during the entire perioperative period.
Step 4 Persistent breakthrough pain in the ward
in a number of patients
Reassessment: leads to the use of intravenous nalbuphine or oral tramadol for
serious breakthrough pain in the ward.
Step 5 Consider intermediate or advanced
solutions depending on resources,
experience and training
Intraoperative regional block
Use of adjuncts to prolong block
Intravenous paracetamol intraoperatively
On the clock systemic analgesia regimen
Oral opioids for breakthrough pain
Day care if appropriate ensuring adequate take home analgesia pack
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assessment should be performed regularly and at least 3 times per
day, with reassessment after analgesia to ensure efficacy. Analgesia
prescriptions should be individualized and adjusted based upon ade-
quate, regular assessments. Invasive techniques such as continuous
opioid infusions, PCA, and NCA require “round-the-clock” availability
of specially trained staff. Table 1 gives an example of quality
improvement using the ESPA Pain Management Ladder.
4 | RECOMMENDATIONS
The following Tables 2-7 provide the Pain Management Ladders for
6 frequently performed procedures in children.
4.1 | Drug and dosage suggestions
Below are some suggestions regarding dosing of some of the drugs
that may be applicable to the different pain management ladder
levels based on the available literature.2,26,44-129 Table 8 shows
dosage suggestions for systemic analgesia, special care must be
taken when prescribing opiods in patients with obstructive sleep
apnea. In Table 9, the reader can find dosage suggestions for regio-
nal anesthesia and Table 10 lists suggestions for the treatment of
PONV.
These are only suggestions and ESPA does not accept any legal
responsibility for these suggestions. Please confer with the pharma-
copeia of your country before using these dosage suggestions. This
TABLE 2 Inguinal hernia repair
Inguinal hernia repair (>1 mo of age)138
Intraoperative Postoperative
Basic level • Rectal NSAID or if not available rectal paracetamol.
43-47
• Local wound infiltration by the surgeon of a long-acting local
anesthetic.
48
• Intravenous fentanyl or morphine to treat break-
through pain in the PACU.
49-53
• Oral NSAIDs and/or paracetamol in adequate dos-
ing during the entire postoperative period.
43-46
Intermediate level • Rectal NSAID or if not available rectal paracetamol
• Landmark-based ilioinguinal/iliohypogastric or caudal blockade
with long-acting local anesthetics  adjunct clonidine if avail-
able.
54,139-141
• Intravenous fentanyl or morphine or other suitable
agent (if available) to treat breakthrough pain in the
PACU.
55,142
• Oral NSAIDs and/or paracetamol in adequate dos-
ing during the entire postoperative period.
• Intravenous nalbuphine or oral tramadol for serious
breakthrough pain in the ward.
56,57,143
Advanced level • Intravenous ketorolac or rectal NSAID.
144
• Intravenous loading dose of paracetamol.
58,59
• Ultrasound-guided peripheral blocks (eg, ilioinguinal/iliohy-
pogastric, TAP, paravertebral or ultrasound-guided caudal
blockade with long-acting local anesthetics combined with
appropriate adjunct).
145-147
• Intravenous fentanyl or morphine or other suitable
agent (if available) to treat breakthrough pain in the
PACU.
• Oral NSAIDs and/or paracetamol in adequate dos-
ing during the entire postoperative period.
• Intravenous nalbuphine or oral tramadol as rescue
in the ward
TABLE 3 Circumcision
Circumcision138
Intraoperative Postoperative
Basic level • Rectal NSAID or if not available rectal paraceta-
mol.
43-47
• Penile block with long-acting local anes-
thetic.
54,139,148
• Intravenous fentanyl or morphine to treat breakthrough pain
in the PACU.
49-53
• Oral NSAIDs (eg, ibuprofen) and/or paracetamol in adequate
dosing during the entire postoperative period.
43-46
Intermediate level • Rectal NSAID or if not available rectal paracetamol
• Penile block or landmark-based caudal blockade
with long-acting local anesthetics  adjunct cloni-
dine if available.
139,149
• Intravenous fentanyl or morphine or other suitable agent (if
available) to treat breakthrough pain in the PACU.
55,142
• Intravenous nalbuphine or other suitable agent (if available) to
treat serious breakthrough pain in the ward.
56,57,143
• Oral NSAIDs (eg, ibuprofen) and/or paracetamol in adequate
dosing during the entire postoperative period
Advanced level • Intravenous ketorolac (if available) or rectal
NSAID.
144
• Intravenous loading dose of paracetamol.
58,59
• Ultrasound-guided penile block or ultrasound-
guided caudal blockade with long-acting local anes-
thetics combined with appropriate adjunct.
150,151
• Intravenous fentanyl or morphine or other suitable agent (if
available) to treat serious breakthrough pain in the PACU.
• Intravenous nalbuphine or other suitable agent (if available) to
treat serious breakthrough pain in the ward.
• Oral NSAIDs (eg, ibuprofen) and/or paracetamol in adequate
dosing during the entire postoperative period
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TABLE 4 Pyloromyotomy
Pyloromyotomy (open and laparoscopic)138,152,153
Intraoperative Postoperative
Basic level • Fentanyl or opioid of choice.
49-53
• Rectal paracetamol
154
• Local wound infiltration/local port-side infiltration by the sur-
geon of a long-acting local anesthetic.
54,139,155,156
• Intravenous fentanyl or other suitable agent (if avail-
able) to treat breakthrough pain in the PACU.
49-53
• Oral or rectal paracetamol in adequate dosing during
the entire postoperative period.
44-46
Intermediate level • Intravenous paracetamol or rectal NSAID.
58,59,154,157
• Landmark-based caudal blockade with long-acting local anes-
thetics  adjunct clonidine if available.158
• Intravenous nalbuphine or other suitable agent (if avail-
able) to treat serious breakthrough pain in the
PACU.
56,57,143
• Oral or rectal NSAIDs (eg, ibuprofen) and/or paraceta-
mol in adequate dosing during the entire postoperative
period.
43
Advanced level • Intravenous metamizole or rectal NSAID.
• Intravenous loading dose of paracetamol.
58,154
• Ultrasound-guided rectus sheath block or bilateral subcostal
TAP or ultrasound-guided caudal blockade with long-acting
local anesthetics combined with appropriate adjunct.
155,159-162
• Intravenous nalbuphine or other suitable agent (if avail-
able) to treat breakthrough pain in the PACU.
• Oral or rectal NSAIDs (eg, ibuprofen) and/or paraceta-
mol in adequate dosing during the entire postoperative
period.
• intravenous nalbuphine or oral tramadol as rescue in
the ward
TABLE 5 Adeno-tonsilectomy
Adeno-tonsillectomy138,163
Warning: In patients with obstructive sleep apnea extra caution is warranted (avoid/minimize opioid dosage, enhance monitoring, longer hospital
stay)131,132
Intraoperative Postoperative
Basic level • Intravenous fentanyl in divided doses
• Rectal NSAID or if not available rectal paracetamol after
induction of anesthesia or oral paracetamol or NSAID as a
part of premedication (preemptive analgesia).
164
• Local wound infiltration by the surgeon of a long-acting local
anesthetic.
60,139,165-169
• Intravenous fentanyl or morphine or other suitable
agent (if available) to treat breakthrough pain in the
PACU
51,170-172
• Oral NSAIDs and/or paracetamol in adequate dosage
during the entire postoperative period from the
moment when the oral intake will be possible.
173,174
• Intravenous or oral tramadol or other suitable agent if
available as rescue in the ward.
175-178
Intermediate level • Intravenous fentanyl or opioid of choice in divided doses
• Loading dose of paracetamol/NSAID intravenously, after
induction of anesthesia. In small children, rectal approach
could be considered as well as oral paracetamol as a part of
premedication (preemptive analgesia).
179-182
• Loading dose of tramadol or other suitable agent if available:
nalbuphine, piritramide before the end of anesthesia.
• Local wound infiltration by the surgeon of a long-acting local
anesthetic.
• Intravenous tramadol or other suitable agent according
to intraoperative loading dose (if available) to treat
serious breakthrough pain in the PACU.
• Intravenous paracetamol in immediate postoperative
period.
183
• Oral NSAIDs and/or paracetamol in adequate dosage
during the entire postoperative period from the
moment when the oral intake is possible.
• Intravenous or oral tramadol or other suitable agent if
available: nalbuphine, piritramide as rescue in the
ward.
143,184,185
Advanced level • Intravenous fentanyl or opioid of choice in divided doses or
remifentanil infusion
• Loading dose of paracetamol/NSAID intravenously, after
induction of anesthesia or loading dose of metamizole. In
small children, rectal approach could be considered as well as
oral paracetamol as a part of premedication (preemptive anal-
gesia).
61,186
• Loading dose of tramadol or other suitable agent if available:
nalbuphine, piritramide before the end of anesthesia.
• Intravenous tramadol or other suitable agent according
to intraoperative loading dose (if available) to treat
breakthrough pain in the PACU.
• Intravenous paracetamol in immediate postoperative
period or
• Metamizole in divided doses.
186
• Oral NSAIDs and/or paracetamol in adequate dosage
during the entire postoperative period from the
moment when the oral intake is possible
• Intravenous or oral tramadol or other suitable agent if
available: nalbuphine, piritramide as rescue in the ward.
• Consider iv-PCA including adequate monitoring
62,187
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TABLE 6 Appendicectomy
Appendicectomy (open and laparoscopic)63,138,188
Intraoperative Postoperative
Basic level • Intravenous fentanyl in divided doses
49
• Local wound infiltration/local port-side infiltration
by the surgeon with a long-acting local anes-
thetic
54,156
• Rectal NSAID or paracetamol
44,45
• Intravenous fentanyl or morphine or other suitable agent (if
available) to treat breakthrough pain in the PACU
50,51,189
• Oral NSAID or paracetamol, in adequate dosing during the
entire postoperative period
• iv or oral tramadol or other suitable agent if available as res-
cue in the ward
56,175
Intermediate level • Intravenous fentanyl or opioid of choice in divided
doses
• Landmark-based ilioinguinal/iliohypogastric block
with long-acting local anesthetic combined with
appropriate adjunct (clonidine)
139
• Intravenous NSAID or loading dose of metami-
zole
61,64
• Intravenous fentanyl or morphine or other suitable agent (if
available) to treat breakthrough pain in the PACU
55
• Intravenous NSAID or paracetamol in adequate dosing during
the entire postoperative period
190
• Intravenous metamizole (if available) in adequate dosing dur-
ing the entire postoperative period
61
• iv or oral tramadol or other suitable agent if available as res-
cue in the ward
Advanced level • Intravenous fentanyl or opioid of choice in divided
doses or remifentanil infusion
• Ultrasound-guided peripheral blocks (eg, ilioin-
guinal/iliohypogastric, transversus abdominis plane
block, paravertebral block with long-acting local
anesthetic combined with appropriate adjunct
(clonidine)
22,191,192
• Intravenous NSAID or loading dose of metamizole
• Intravenous fentanyl or other suitable agent (if available) to
treat breakthrough pain in the PACU
• Intravenous NSAID, or paracetamol or metamizole in adequate
dosing during the entire postoperative period
• iv or oral tramadol or other suitable agent if available as res-
cue in the ward or
• Consider iv-PCA (patient controlled analgesia) including ade-
quate monitoring.
65,66,193
TABLE 7 Limb fractures
Limb fractures (>1 mo of age)138
Intraoperative Postoperative
Basic level • Fentanyl or opioid of choice in divided doses
49
• Rectal NSAID or rectal paracetamol
44,45
• If possible fracture infiltration by the surgeon with long-acting local
anesthetic
• Intravenous morphine or fentanyl or morphine or
other suitable agent (if available) to treat break-
through pain in the PACU
50,51,55,67
• Oral NSAIDs and/or paracetamol in adequate dos-
ing during the entire postoperative period.
• iv or oral tramadol or other suitable agent (if avail-
able) as rescue in the ward
56
Intermediate level • Intravenous NSAID or intravenous paracetamol
• Landmark-guided peripheral nerve block (eg, interscalene, supraclavic-
ular, axillar block for the upper limb; femoral, adductor canal, sciatic
block, eventually in association, for the lower limb) with a long-acting
local anesthetic combined with appropriate adjunct (clonidine) if avail-
able. If using a double block consider the total amount of local anes-
thetic.
54,139,194-197
• If PNB is contraindicated fentanyl or opioid if choice in divided doses
• Intravenous morphine or fentanyl or other suitable
agent (if available) to treat breakthrough pain in the
PACU
• Oral NSAIDs and/or paracetamol in adequate dos-
ing during the entire postoperative period.
• iv or oral tramadol or other suitable agent (if avail-
able) as rescue in the ward
Advanced level • Intravenous ketorolac.
• Intravenous loading dose of intravenous NSAID or paracetamol.
• Ultrasound-guided peripheral nerve block single, shot or continuous
infusion, (eg, interscalene, supraclavicular, axillar block for the upper
limb; femoral, adductor canal, sciatic block, eventually in association,
for the lower limb) with a long-acting local anesthetic combined with
appropriate adjunct (clonidine) if available. If using a double block
consider the total amount of local anesthetic.
198-202
• If PNB is contraindicated: fentanyl or opioid of choice in divided
doses.
• Intravenous fentanyl or other suitable agent (if
available) to treat serious breakthrough pain in the
PACU.
• iv/oral paracetamol or iv/oral NSAID in adequate
dosing during the entire postoperative period.
203
• iv or oral tramadol or other suitable agent (if avail-
able) as rescue in the ward
• Consider patient-controlled regional anesthesia or
iv-PCA if needed
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TABLE 8 Dosage suggestions for systemic analgesia
Basic level Intermediate level Advanced level Dosage suggestions
Rectal NSAIDs (Nonsteroidal anti-inflammatory drugs)
Ibuprofen Ibuprofen Ibuprofen 10 mg kg1 every 8 h
Diclofenac Diclofenac Diclofenac 1 mg kg1 every 8 h
Naproxen Naproxen Naproxen 5-7.5 mg kg1 every 12 h
Oral NSAIDs
Ibuprofen Ibuprofen Ibuprofen 10 mg kg1 every 8 h
Diclofenac Diclofenac Diclofenac 1 mg kg1 every 8 h
Intravenous NSAIDs
Ketorolac 0.5-1 mg kg1 kg up to 30 mg for a single intraoperative
dose 0.15-0.2 mg kg1 (max 10 mg) every 6 h
(short-term therapy, maximum 48 h)
Ketoprofen 1 mg kg1 every 8 h
Rectal paracetamol (if rectal NSAID is not available)
Paracetamol Paracetamol Paracetamol 20-40 mg kg1 (15 mg kg1 if <10 kg)
Single loading dose in association with anesthesia; the
higher dose is due to poor bioavailability from rectal
route of administration
Oral paracetamol
Paracetamol Paracetamol Paracetamol 10-15 mg kg1 every 6 h
Intravenous paracetamol
Paracetamol <10 kg: 7,5 mg kg1
>10 kg: 15 mg kg1
Intravenous preparation: 10 mg mL1
Intraoperative opioids depending on age and procedure
Fentanyl Fentanyl Fentanyl 1-2 lg kg1
Morphine Morphine Morphine 25-100 lg kg1 depending on age, titrated to effect
Piritramide Piritramide 0.1-0.15 mg kg1
Alfentanil Alfentanil 10-20 lg kg1
Sufentanil Sufentanil 0.5-1 lg kg1 bolus
Sufentanil 0.5-1 lg kg1 bolus then continuous infusion of 0.5-1 lg kg1 h1
Remifentanil 0.05-0.3 lg kg1 min1
Intraoperative use of ketamine/S-ketamine
Ketamine/S-Ketamine Ketamine/S-Ketamine Ketamine/S-Ketamine 0.5 mg kg1 may be used as adjunct to intraoperative
opioids, consider reduced dose when using S-ketamine
Intraoperative/postoperative intravenous Metamizol
Metamizole 10-15 mg kg1 every 8 h
2.5 mg kg1 h1 (continuous infusion following
an intraoperative loading dose)
(Due to the risk of agranulocytosis after long-term use
metamizole is recommended for short term postoperative
use in a hospital setting only)
Intravenous analgesics for breakthrough pain in PACU depending on age and procedure
Fentanyl Fentanyl Fentanyl 0.5-1.0 lg kg1, titrated to effect
Morphine Morphine Morphine 25-100 lg kg1 depending on age, titrated to effect
Tramadol Tramadol Tramadol 1-1.5 mg kg1, titrated to effect
Ketamine/S-Ketamine Ketamine/S-Ketamine Ketamine/S-Ketamine 0.5 mg kg1, titrated to effect, consider reduced dose when
using S-ketamine
Piritramide Piritramide 0.1-0.15 mg kg1, titrated to effect
Nalbuphine Nalbuphine 0.1-0.2 mg kg1, depending on age, titrated to effect
(Continues)
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also applies to maximum drug doses that may be used. Some of
the analgesic drugs or formulations may not be available in all
counties.
Be aware of increased sensitivity to the effects of opioids in
patients with obstructive sleep apnea (OSA) and markedly increased
risk of opioid-induced ventilatory impairment (OIVI) in the
TABLE 8 (Continued)
Basic level Intermediate level Advanced level Dosage suggestions
Intravenous analgesics for breakthrough pain in the ward
Tramadol Tramadol Tramadol 1-1.5 mg kg1, every 4-6 h
Nalbuphine Nalbuphine 0.1-0.2 mg kg1, depending on age, every 3-4 h
Piritramide Piritramide 0.1-0.15 mg kg1 every 4-6 h
Metamizole Metamizole 10-15 mg kg1 every 8 h
Oral analgesics for breakthrough pain in the ward
Tramadol Tramadol Tramadol 1-1.5 mg kg1, every 4-6 h
Metamizole Metamizole 10 mg kg1 every 8 h
Patient Controlled Analgesia (PCA) including adequate monitoring
Morphine PCA according to institutional standards based on the current literature
Fentanyl PCA according to institutional standards based on the current literature
Piritramide PCA according to institutional standards based on the current literature
Tramadol/Metamizole PCA according to institutional standards based on the current literature
TABLE 9 Dosage suggestions for regional anesthesia
Dosage suggestions Adjuvant
Long-acting local anesthetics for wound infiltration, port-side infiltration, fracture infiltration or peripheral nerve block
Bupivacaine 0.25% Maximum dose 1 mL kg1 (=2.5 mg kg1)
L-bupivacaine 0.25% Maximum dose 1 mL kg1 (=2.5 mg kg1)
Ropivacaine 0.2% Maximum dose 1.5 mL kg1 (=3 mg kg1)
Long-acting local anesthetics for landmark-based ilioinguinal/iliohypogastric nerve block
Bupivacaine 0.25% 0.3-0.5 mL kg1 (=0.75-1.25 mg kg1) If available, consider the use of preservative-free
clonidine 1-2 lg kg1 as adjunct
L-bupivacaine 0.25% 0.3-0.5 mL kg1 (=0.75-1.25 mg kg1)
Ropivacaine 0.2% 0.3-0.5 mL kg1 (=0.6-1 mg kg1)
Long-acting local anesthetics for landmark-based and ultrasound-guided caudal block
Bupivacaine 0.25% 1.0 mL kg1 (up to 1.5 mL kg1 for pyloromyotomy) Preservative-free clonidine 1-2 lg kg1 or
Preservative-free ketamine or
S-ketamine if >12 mo of age: 0.5-1 mg kg1
L-bupivacaine 0.25% 1.0 mL kg1 (up to 1.5 mL kg1 for pyloromyotomy)
Ropivacaine 0.2% 1.0 mL kg1 (up to 1.5 mL kg1 for pyloromyotomy)
Long-acting local anesthetics for ultrasound-guided ilioinguinal/iliohypogastric nerve block and paravertebral block
Bupivacaine 0.25% 0.1-0.2 mL kg1 Preservative-free clonidine 1-2 lg kg1
L-bupivacaine 0.25% 0.1-0.2 mL kg1
Ropivacaine 0.2% 0.1-0.2 mL kg1
Long-acting local anesthetics for landmark-based and ultrasound-guided dorsal penile nerve block
Bupivacaine 0.25% 0.1-0.2 mL kg1 Preservative-free clonidine 1-2 lg kg1
L-bupivacaine 0.25% 0.1-0.2 mL kg1
Ropivacaine 0.2% 0.1-0.2 mL kg1
Long-acting local anesthetics for ultrasound-guided rectus sheath block and subcostal TAP:
Bupivacaine 0.25% 0.2-0.5 mL kg1 per side Preservative-free clonidine 1 lg kg1 per side
L-bupivacaine 0.25% 0.2-0.5 mL kg1 per side
Ropivacaine 0.2% 0.2-0.5 mL kg1 per side
Continuous or patient controlled regional anesthesia including adequate monitoring
According to institutional standards based on the current literature Preservative-free clonidine 0.2-0.4 lg kg1 h1
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postoperative period.130 It is recommended that opioids should be
avoided in the postoperative period in this population if possible or
if needed, minimize opioid dosage (25%-50% of usual dosage), and
titrate dose to effect with enhanced postoperative monitoring and
longer hospital stay.131,132
4.1.1 | Monitoring standards
Clinical and electronic monitoring standards will depend on age, co-
morbidities, extent and complexity of the surgery, and use of seda-
tive medications. Particular care is required in infants <1 year of age,
when opioid infusion techniques are used and where surgery
becomes complicated. Specific monitoring for complications of regio-
nal analgesic techniques should be used, especially for continuous
infusion techniques and in younger infants. For details on monitoring
and treatment of possible adverse effects, the ESPA pain manage-
ment committee suggests following already available recommenda-
tions such as those published by the Australian and New Zealand
College of Anesthetists or the Association of Pediatric Anesthetists
of Great Britain and Ireland.8,133,134 Concerning the safe use of
regional anesthesia in children, the joint practice advisory from the
European Society of Regional Anaesthesia and Pain Therapy (ESRA)
and the American Society of Regional Anesthesia and Pain Medicine
(ASRA) is recommended.135
4.1.2 | Use of corticosteroids
Corticosteroids may enhance postoperative pain relief and prolong
the duration of regional anesthesia and help to prevent postopera-
tive nausea and vomiting.136,137
5 | CONCLUSIONS
The ESPA Pain Ladder is a synthesis of existing guidelines, availability
of medications and other resources, economic costs, and patient safety.
We hope that the suggestions in this article will help improve pediatric
postoperative analgesia in Europe and other parts of the world.
ETHICAL APPROVAL
No ethics approval provided.
CONFLICT OF INTEREST
All authors declare no conflict of interest.
ORCID
Maria Vittinghoff http://orcid.org/0000-0003-0286-6636
Per-Arne L€onnqvist http://orcid.org/0000-0002-8586-1429
REFERENCES
1. Cousins MJ, Lynch ME. The Declaration Montreal: access to pain
management is a fundamental human right. Pain. 2011;152:2673-
2674.
2. Rabbitts JA, Groenewald CB, R€as€anen J. Geographic differences in
perioperative opioid administration in children. Pediatr Anesth.
2012;22:676-681.
3. Mezdrzycka-Dazbrowska W, Dazbrowski S, Basinski A. Problems and
barriers in ensuring effective acute and postoperative pain manage-
ment—an international perspective. Adv Clin Exp Med.
2015;24:905-910.
4. Kost-Byerly S. New concepts in acute and extended postoperative
pain management in children. Anesthesiol Clin North America.
2002;20:115-135.
5. Sng QW, He H-G, Wang W, et al. A meta-synthesis of children’s
experiences of postoperative pain management. Worldviews Evid
Based Nurs. 2017;14:46-54.
6. Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of
Postoperative Pain: a clinical practice guideline from the american
pain society, the American Society of Regional Anesthesia and Pain
Medicine, and the American Society of Anesthesiologists’ Commit-
tee on Regional Anesthesia, Executive Committee, and Administra-
tive Council. J Pain. 2016;17:131-157.
7. Walker SM. Pain after surgery in children. Curr Opin Anaesthesiol.
2015;28:570-576.
8. Association of Paediatric Anaesthetists of Great Britain and Ireland.
Good practice in postoperative and procedural pain management,
2nd Edition. Pediatr Anesth. 2012;22:1-79.
9. Howard R, Carter B, Curry J, et al. Good practice in postoperative
and procedural pain management. Background. Pediatr Anesth.
2008;18(suppl 1):1-3.
10. Jaksch W, Messerer B, Baumgart H, et al. Austrian interdisciplinary
recommendations on pediatric perioperative pain management:
background, aims, methods and key messages. Schmerz. 2014;28:7-
13.
11. Habre W, Disma N, Virag K, et al. Incidence of severe critical
events in paediatric anaesthesia (APRICOT): a prospective multicen-
tre observational study in 261 hospitals in Europe. Lancet Respir
Med. 2017;5:412-425.
12. Walther-Larsen S, Pedersen MT, Friis SM, et al. Pain prevalence in
hospitalized children: a prospective cross-sectional survey in four
Danish university hospitals. Acta Anaesthesiol Scand. 2017;61:328-
337.
13. Alm F, Jaensson M, Lundeberg S, Ericsson E. Adherence to Swedish
guidelines for pain treatment in relation to pediatric tonsil surgery:
a survey of the multidisciplinary team. Int J Pediatr Otorhinolaryngol.
2017;101:123-131.
14. World Health Organization. WHO’s cancer pain ladder for adults.
WHO. World Health Organization; 2013. http://www.who.int/ca
ncer/palliative/painladder/en/. Accessed November 13, 2017.
15. Yaster M. Multimodal analgesia in children. Eur J Anaesthesiol.
2010;27:851-857.
TABLE 10 Treatment of postoperative nausea and vomiting
(PONV)
Dosage suggestions
Dexamethasone 0.15 mg kg1 every 8 h
Ondansetron 0.05-0.1 mg kg1 every 8 h Not to be combined
with tramadol
Metoclopramide 0.1 mg kg1 every 8 h Not to be combined
with tramadol;
not if <1 y old
VITTINGHOFF ET AL. | 501
16. Wong I, St John-Green C, Walker SM. Opioid-sparing effects of
perioperative paracetamol and nonsteroidal anti-inflammatory drugs
(NSAIDs) in children, Lonnqvist P-A, editor. Pediatr Anesth.
2013;23:475-495.
17. Schug SA, Manopas A. Update on the role of non-opioids for post-
operative pain treatment. Best Pract Res Clin Anaesthesiol.
2007;21:15-30.
18. J€ohr M. Practical pediatric regional anesthesia. Curr Opin Anaesthe-
siol. 2013;26:327-332.
19. Ivani G, Mosseti V. Pediatric regional anesthesia. Minerva Anestesiol.
2009;75:577-583.
20. L€onnqvist P-A. Blocks for pain management in children undergoing
ambulatory surgery. Curr Opin Anaesthesiol. 2011;24:627-632.
21. L€onnqvist P-A. Is ultrasound guidance mandatory when performing
paediatric regional anaesthesia? Curr Opin Anaesthesiol. 2010;23:
337-341.
22. Sandeman DJ, Bennett M, Dilley AV, Perczuk A, Lim S, Kelly KJ.
Ultrasound-guided transversus abdominis plane blocks for laparo-
scopic appendicectomy in children: a prospective randomized trial.
Br J Anaesth. 2011;106:882-886.
23. Xue FS, Liu KP, Liu Y, et al. Assessment of small-dose fentanyl and
sufentanil blunting the cardiovascular responses to laryngoscopy
and intubation in children. Pediatr Anesth. 2007;17:568-574.
24. Xue FS, Xu YC, Liu Y, et al. Different small-dose sufentanil blunting
cardiovascular responses to laryngoscopy and intubation in children:
a randomized, double-blind comparison. Br J Anaesth. 2008;100:
717-723.
25. Elshammaa N, Chidambaran V, Housny W, Thomas J, Zhang X,
Michael R. Ketamine as an adjunct to fentanyl improves postopera-
tive analgesia and hastens discharge in children following tonsillec-
tomy - a prospective, double-blinded, randomized study. Pediatr
Anesth. 2011;21:1009-1014.
26. Dahmani S, Michelet D, Abback PS, et al. Ketamine for periopera-
tive pain management in children: a meta-analysis of published
studies. Pediatr Anesth. 2011;21:636-652.
27. Colvin JR, Peden CJ. Raising the Standard: a compendium of audit
recipes. 3rd Edition. The Royal College of Anaesthetists; 2012.
https://www.rcoa.ac.uk/system/files/CSQ-ARB-2012_0.pdf.
Accessed January 30, 2018.
28. Redmann AJ, Wang Y, Furstein J, Myer CM, de Alarcon A. The use
of the FLACC pain scale in pediatric patients undergoing adenoton-
sillectomy. Int J Pediatr Otorhinolaryngol. 2017;92:115-118.
29. Crellin DJ, Harrison D, Santamaria N, Babl FE. Systematic review of
the Face, Legs, Activity, Cry and Consolability scale for assessing
pain in infants and children: is it reliable, valid, and feasible for use?
Pain. 2015;156:2132-2151.
30. B€uttner W, Finke W. Analysis of behavioural and physiological
parameters for the assessment of postoperative analgesic demand
in newborns, infants and young children: a comprehensive report
on seven consecutive studies. Pediatr Anesth. 2000;10:303-318.
31. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough
B. The Faces Pain Scale-Revised: toward a common metric in pedi-
atric pain measurement. Pain. 2001;93:173-183.
32. Miro J, Castarlenas E, de la Vega R, et al. Validity of three rating
scales for measuring pain intensity in youths with physical disabili-
ties. Eur J Pain. 2016;20:130-137.
33. Bailey B, Gravel J, Daoust R. Reliability of the visual analog scale in
children with acute pain in the emergency department. Pain.
2012;153:839-842.
34. The Royal College of Nursing. The recognition and assessment of
acute pain in children - Update of full guideline; 2009. https://
www.rcn.org.uk/professional-development/publications/pub-
003542. Accessed January 30, 2018.
35. Kost-Byerly S, Chalkiadis G. Developing a pediatric pain service. Pe-
diatr Anesth. 2012;22:1016-1024.
36. Valizadeh F, Ahmadi F, Zarea K. Neglect of postoperative pain man-
agement in children: a qualitative study based on the experiences
of parents. J Pediatr Nurs. 2016;31:439-448.
37. Bertini L. Pain free hospital: organisation aspects. Minerva Aneste-
siol. 2001;67(9 suppl 1):181-186.
38. Willschke H, Marhofer P, B€osenberg A, et al. Ultrasonography for
ilioinguinal/iliohypogastric nerve blocks in children. Br J Anaesth.
2005;95:226-230.
39. Willschke H, B€osenberg A, Marhofer P, et al. Ultrasonographic-
guided ilioinguinal/iliohypogastric nerve block in pediatric anesthe-
sia: what is the optimal volume? Anesth Analg. 2006;102:1680-
1684.
40. Holmer Pettersson P, Owall A, Jakobsson J. Early bioavailability of
paracetamol after oral or intravenous administration. Acta Anaesthe-
siol Scand. 2004;48:867-870.
41. Lockie J, Bartholomew K, Cranston A, Gildersleve C. Chapter
10 Guidelines for the provision of paediatric anaesthesia
services 2017. The Royal College of Anaesthetist; 2017.
https://www.rcoa.ac.uk/gpas2017. Accessed January 30, 2018.
42. Burke J. A happy ward by friday. Presentation, Pietermaritzburg:
PACSA; 2016.
43. Walther-Larsen S, Aagaard GB, Friis SM, Petersen T, Møller-Son-
nergaard J, Rømsing J. Structured intervention for management of
pain following day surgery in children, Lonnqvist P-A, editor. Pediatr
Anesth. 2016;26:151-157.
44. Kokki H. Nonsteroidal anti-inflammatory drugs for postoperative
pain: a focus on children. Paediatr Drugs. 2003;5:103-123.
45. Litalien C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-
inflammatory drugs in children: a comparison with paracetamol.
Paediatr Drugs. 2001;3:817-858.
46. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibupro-
fen for acute postoperative pain in adults. Cochrane Database Syst
Rev. 2009;3:CD001548.
47. Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetamino-
phen in children and adults: a meta-analysis and qualitative review.
Ann Pharmacother. 2010;44:489-506.
48. Mobley KA, Wandless JG, Fell D. Serum bupivacaine concentrations
following wound infiltration in children undergoing inguinal herniot-
omy. Anaesthesia. 1991;46:500-501.
49. Pasero C. Fentanyl for acute pain management. J Perianesth Nurs.
2005;20:279-284.
50. Conti G, Costa R, Pellegrini A, Craba A, Cavaliere F. Analgesia in
PACU: intravenous opioids. Curr Drug Targets. 2005;6:767-771.
51. Aubrun F, Mazoit J-X, Riou B. Postoperative intravenous morphine
titration. Br J Anaesth. 2012;108:193-201.
52. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine
in neonates, infants and children based on a literature review: part
1–Pharmacokinetics. Pediatr Anesth. 1997;7:5-11.
53. Duedahl TH, Hansen EH. A qualitative systematic review of mor-
phine treatment in children with postoperative pain. Pediatr Anesth.
2007;17:756-774.
54. Mazoit J-X, Dalens BJ. Pharmacokinetics of local anaesthetics in
infants and children. Clin Pharmacokinet. 2004;43:17-32.
55. Laskowski K, Stirling A, McKay WP, Lim HJ. A systematic review of
intravenous ketamine for postoperative analgesia. Can J Anaesth.
2011;58:911-923.
56. Bozkurt P. Use of tramadol in children. Pediatr Anesth.
2005;15:1041-1047.
57. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine
JD. The kappa opioid nalbuphine produces gender- and dose-
dependent analgesia and antianalgesia in patients with postopera-
tive pain. Pain. 1999;83:339-345.
58. Wilson-Smith EM, Morton NS. Survey of i.v. paracetamol (ac-
etaminophen) use in neonates and infants under 1 year of age by
UK anesthetists. Pediatr Anesth. 2009;19:329-337.
502 | VITTINGHOFF ET AL.
59. McNicol ED, Ferguson MC, Haroutounian S, Carr DB, Schumann R.
Single dose intravenous paracetamol or intravenous propacetamol
for postoperative pain. Cochrane Database Syst Rev. 2016;5:
CD007126.
60. Wong AK, Bissonnette B, Braude BM, Macdonald RM, St-Louis PJ,
Fear DW. Post-tonsillectomy infiltration with bupivacaine reduces
immediate postoperative pain in children. Can J Anaesth.
1995;42:770-774.
61. Fieler M, Eich C, Becke K, et al. Metamizole for postoperative
pain therapy in 1177 children: a prospective, multicentre, obser-
vational, postauthorisation safety study. Eur J Anaesthesiol.
2015;32:1-5.
62. Momeni M, Crucitti M, De Kock M. Patient-controlled analgesia in
the management of postoperative pain. Drugs. 2006;66:2321-2337.
63. Manworren RCB, McElligott CD, Deraska PV, et al. Efficacy of anal-
gesic treatments to manage children’s postoperative pain after
laparoscopic appendectomy: retrospective medical record review.
AORN J. 2016;103:317.e1-11.
64. Fendrich Z. Metamizol-a new effective analgesic with a long his-
tory. Overview of its pharmacology and clinical use. Cas Lek Cesk.
2000;139:440-444.
65. Ousley R, Burgoyne LL, Crowley NR, Teague WJ, Costi D. An audit
of patient-controlled analgesia after appendicectomy in children.
Pediatr Anesth. 2016;26:1002-1009.
66. Morton NS, O’Brien K. Analgesic efficacy of paracetamol and
diclofenac in children receiving PCA morphine. Br J Anaesth.
1999;82:715-717.
67. Petrat G, Klein U, Meissner W. On-demand analgesia with pir-
itramide in children. A study on dosage specification and safety. Eur
J Pediatr Surg. 1997;7:38-41.
68. Steans A, Manners PJ, Robinson IG. A multicentre, long-term evalu-
ation of the safety and efficacy of ibuprofen syrup in children with
juvenile chronic arthritis. Br J Clin Pract. 1990;44:172-175.
69. Van Der Marel CD, Anderson BJ, Rømsing J, Jacqz-Aigrain E, Tib-
boel D. Diclofenac and metabolite pharmacokinetics in children. Pe-
diatr Anesth. 2004;14:443-451.
70. Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute
treatment of migraine in children and adolescents. Cochrane Data-
base Syst Rev. 2016;4:CD005220.
71. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral
naproxen and naproxen sodium for acute postoperative pain in
adults. Cochrane Database Syst Rev. 2009:CD004234.
72. Mohammed BS, Engelhardt T, Hawwa AF, Cameron GA, McLay JS.
The enantioselective population pharmacokinetics of intravenous
ketorolac in children using a stereoselective assay suitable for
microanalysis. J Pharm Pharmacol. 2015;67:1179-1187.
73. Baley K, Michalov K, Kossick MA, McDowell M. Intravenous aceta-
minophen and intravenous ketorolac for management of pediatric
surgical pain: a literature review. AANA J. 2014;82:53-64.
74. Kokki H, Karvinen M, Jekunen A. Pharmacokinetics of a 24-hour
intravenous ketoprofen infusion in children. Acta Anaesthesiol
Scand. 2002;46:194-198.
75. Kokki H. Ketoprofen pharmacokinetics, efficacy, and tolerability in
pediatric patients. Paediatr Drugs. 2010;12:313-329.
76. Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action.
Pediatr Anesth. 2008;18:915-921.
77. Birmingham PK, Tobin MJ, Fisher DM, Henthorn TK, Hall SC, Cote
CJ. Initial and subsequent dosing of rectal acetaminophen in chil-
dren: a 24-hour pharmacokinetic study of new dose recommenda-
tions. Anesthesiology. 2001;94:385-389.
78. Lavonas EJ, Reynolds KM, Dart RC. Therapeutic acetaminophen is
not associated with liver injury in children: a systematic review.
Pediatrics. 2009;126:1430-1444.
79. Jahr JS, Lee VK. Intravenous acetaminophen. Anesthesiol Clin.
2010;28:619-645.
80. Becke K. Generous use of opioids is advantageous for infants and
children–Pro. Anasthesiol Intensivmed Notfallmed Schmerzther.
2010;45:470-472.
81. Ginsberg B, Howell S, Glass PS, et al. Pharmacokinetic model-driven
infusion of fentanyl in children. Anesthesiology. 1996;85:1268-1275.
82. Leoni F, Benni F, Iacobucci T, de Francisci G. Pain control with low-
dose alfentanil in children undergoing minor abdominal and genito-
urinary surgery. Eur J Anaesthesiol. 2004;21:738-742.
83. Ganidagli S, Cengiz M, Baysal Z. Remifentanil vs alfentanil in the
total intravenous anaesthesia for paediatric abdominal surgery. Pe-
diatr Anesth. 2003;13:695-700.
84. Kwak HJ, Kim JY, Kim YB, Chae YJ, Kim JY. The optimum bolus
dose of remifentanil to facilitate laryngeal mask airway insertion
with a single standard dose of propofol at induction in children.
Anaesthesia. 2008;63:954-958.
85. Beers R, Camporesi E. Remifentanil update: clinical science and util-
ity. CNS Drugs. 2004;18:1085-1104.
86. Bakan M, Dogan Z, Esen A. Practical use of remifentanil for pedi-
atric patients. Pediatr Anesth. 2011;21:1074-1075.
87. Sammartino M, Garra R, Sbaraglia F, De Riso M, Continolo N.
Remifentanil in children. Pediatr Anesth. 2010;20:246-255.
88. Staschen CM, Mahmood I. A population pharmacokinetic model of
remifentanil in pediatric patients using bodyweight-dependent allo-
metric exponents. Drug Metabol Drug Interact. 2013;28:231-237.
89. Huenseler C, Borucki D, Mueller C, et al. Prospective evaluation of
the pharmacodynamics of piritramide in neonates and infants. Eur J
Pediatr. 2008;167:867-872.
90. M€uller C, Kremer W, Harlfinger S, et al. Pharmacokinetics of pir-
itramide in newborns, infants and young children in intensive care
units. Eur J Pediatr. 2006;165:229-239.
91. Olkkola KT, Maunuksela EL, Korpela R, Rosenberg PH. Kinetics and
dynamics of postoperative intravenous morphine in children. Clin
Pharmacol Ther. 1988;44:128-136.
92. Morton NS, Errera A. APA national audit of pediatric opioid infu-
sions. Pediatr Anesth. 2010;20:119-125.
93. Lundeberg S, Roelofse JA. Aspects of pharmacokinetics and phar-
macodynamics of sufentanil in pediatric practice. Pediatr Anesth.
2011;21:274-279.
94. Soulard A, Babre F, Bordes M, Meymat Y, Sztark F, Cros AM. Opti-
mal dose of sufentanil in children for intubation after sevoflurane
induction without neuromuscular block. Br J Anaesth.
2009;102:680-685.
95. Hinz B, Cheremina O, Bachmakov J, et al. Dipyrone elicits substan-
tial inhibition of peripheral cyclooxygenases in humans: new
insights into the pharmacology of an old analgesic. FASEB J.
2007;21:2343-2351.
96. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NHG. Develop-
mental pharmacokinetics of morphine and its metabolites in neo-
nates, infants and young children. Br J Anaesth. 2004;92:208-217.
97. Kurihara Y, Kagawa T, Suzuki T, Ohnishi H, Ikeshma N. Efficacy and
complications of fentanyl intravenous infusions in postoperative
pediatric patients. Japan J Anesthesiol. 2008;57:1419-1420.
98. Bell RF, Dahl JB, Moore RA, Kalso E. Peri-operative ketamine for
acute post-operative pain: a quantitative and qualitative systematic
review. Acta Anaesthesiol Scand. 2005;49:1405-1428.
99. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Sch€uttler
J. Differential modulation of remifentanil-induced analgesia and
postinfusion hyperalgesia by S-ketamine and clonidine in humans.
Anesthesiology. 2003;99:152-159.
100. Anderson BJ, Palmer GM. Recent pharmacological advances in pae-
diatric analgesics. Biomed Pharmacother. 2006;60:303-309.
101. Finkel JC, Rose JB, Schmitz ML, et al. An evaluation of the efficacy
and tolerability of oral tramadol hydrochloride tablets for the treat-
ment of postsurgical pain in children. Anesth Analg. 2002;94:1469-
1473.
VITTINGHOFF ET AL. | 503
102. Steffen P, Krinn E, M€oller A, Seeling W, Rockemann MG. Metami-
zol and diclofenac profoundly reduce opioid consumption after
minor trauma surgery. Acute Pain. 2002;4:71-75.
103. Carstensen M, Moller AM. Adding ketamine to morphine for intra-
venous patient-controlled analgesia for acute postoperative pain: a
qualitative review of randomized trials. Br J Anaesth.
2010;104:401-406.
104. Cha MH, Eom JH, Lee YS, et al. Beneficial effects of adding keta-
mine to intravenous patient-controlled analgesia with fentanyl after
the nuss procedure in pediatric patients. Yonsei Med J.
2012;53:427-432.
105. Rugyte D, Edberg KE. Patient-controlled analgesia in the treatment
of postoperative pain in children and adolescents. Medicina.
2002;38:1078-1082.
106. Hudcova J, McNicol E, Quah C, Lau J, Carr DB. Patient controlled
opioid analgesia versus conventional opioid analgesia for postoper-
ative pain. Cochrane Database Syst Rev. 2006:CD003348.
107. Tobias JD, Baker DK. Patient-controlled analgesia with fentanyl in
children. Clin Pediatr. 1992;31:177-179.
108. Spacek A, Goraj E, Neiger FX, Jarosz J, Kress HG. Superior postoper-
ative analgesic efficacy of a continuous infusion of tramadol and
dipyrone (metamizol) versus tramadol alone. Acute Pain. 2003;5:3-9.
109. Stamer UM, H€othker F, Lehnen K, St€uber F. Postoperative analge-
sie mit tramadol und metamizol. Kontinuierliche infusion versus
patientenkontrollierte analgesie. Anaesthesist. 2003;52:33-41.
110. Tsuchiya N, Ichizawa M, Yoshikawa Y, Shinomura T. Comparison of
ropivacaine with bupivacaine and lidocaine for ilioinguinal block
after ambulatory inguinal hernia repair in children. Pediatr Anesth.
2004;14:468-470.
111. Dalens B, Ecoffey C, Joly A, et al. Pharmacokinetics and analgesic
effect of ropivacaine following ilioinguinal/iliohypogastric nerve
block in children. Pediatr Anesth. 2001;11:415-420.
112. Das H, Ghosh S, Laha A. Comparison of caudal analgesia between
ropivacaine and ropivacaine with clonidine in children: a random-
ized controlled trial. Saudi J Anaesth. 2012;6:197-200.
113. Sola C, Menace C, Rochette A, et al. Ultrasound-guided tranversus
abdominis plane block for herniorrhaphy in children: what is the
optimal dose of levobupivacaine? Eur J Anaesthesiol. 2014;31:327-
332.
114. Ivani G. Ropivacaine: is it time for children? Pediatr Anesth.
2002;12:383-387.
115. Ivani G, Mazzarello G, Lampugnani E, DeNegri P, Torre M, Lon-
nqvist PA. Ropivacaine for central blocks in children. Anaesthesia.
1998;53(suppl 2):74-76.
116. Ingelmo P, Ingelmo G, Astuto M, et al. Relative analgesic potencies
of levobupivacaine and ropivacaine for caudal anesthesia in chil-
dren. Anesth Analg. 2009;108:805-813.
117. Breschan C, Jost R, Krumpholz R, et al. A prospective study com-
paring the analgesic efficacy of levobupivacaine, ropivacaine and
bupivacaine in pediatric patients undergoing caudal blockade. Pedi-
atr Anesth. 2005;15:301-306.
118. Ivani G, DeNegri P, Conio A, et al. Comparison of racemic bupiva-
caine, ropivacaine, and levo-bupivacaine for pediatric caudal anes-
thesia: effects on postoperative analgesia and motor block. Reg
Anesth Pain Med. 2002;27:157-161.
119. Akin A, Ocalan S, Esmaoglu A, Boyaci A. The effects of caudal or
intravenous clonidine on postoperative analgesia produced by cau-
dal levobupivacaine in children. Pediatr Anesth. 2010;20:350-355.
120. She YJ, Xie GT, Tan YH, et al. A prospective study comparing the
onset and analgesic efficacy of different concentrations of
levobupivacaine with/without dexmedetomidine in young children
undergoing caudal blockade. J Clin Anesth. 2015;27:17-22.
121. Moriceau F, Geffard B, Duflo F. Levobupivacaine for continuous
femoral nerve block in paediatric patients: a plasma concentration
analysis report on safety. Anaesth Crit Care Pain Med. 2015;34:183.
122. H€ohne C. Postoperative nausea and vomiting in pediatric anesthe-
sia. Curr Opin Anaesthesiol. 2014;27:303-308.
123. Breitfeld C, Peters J, Vockel T, Lorenz C, Eikermann M. Emetic
effects of morphine and piritramide. Br J Anaesth. 2003;91:218-
223.
124. Park YH, Jang YE, Byon HJ, Kim JT, Kim HS. Comparison of the
efficacy of ramosetron and ondansetron in the prophylaxis of post-
operative vomiting in children receiving fentanyl by patient-con-
trolled analgesia after orthopedic surgery: a randomized controlled
trial. Pediatr Anesth. 2013;23:360-364.
125. Wang X-X, Zhou Q, Pan D-B, et al. Dexamethasone versus ondan-
setron in the prevention of postoperative nausea and vomiting in
patients undergoing laparoscopic surgery: a meta-analysis of ran-
domized controlled trials. BMC Anesthesiol. 2015;15:118.
126. Sekhavat L, Davar R, Behdad S. Efficacy of prophylactic dexam-
ethasone in prevention of postoperative nausea and vomiting. J
Epidemiol Glob Health. 2015;5:175-179.
127. De Orange FA, Marques J, Flores M, Borges PSGN. Dexametha-
sone versus ondansetron in combination with dexamethasone for
the prophylaxis of postoperative vomiting in pediatric outpatients:
a double-blind, randomized, placebo-controlled clinical trial. Pediatr
Anesth. 2012;22:890-896.
128. Leksowski K, Peryga P, Szyca R. Ondansetron, metoclopramid, dex-
amethason, and their combinations compared for the prevention of
postoperative nausea and vomiting in patients undergoing laparo-
scopic cholecystectomy: a prospective randomized study. Surg
Endosc. 2006;20:878-882.
129. Arcioni R, della Rocca M, Romano S, Romano R, Pietropaoli P, Gas-
paretto A. Ondansetron inhibits the analgesic effects of tramadol: a
possible 5-HT(3) spinal receptor involvement in acute pain in
humans. Anesth Analg. 2002;94:1553-1557.
130. Lam KK, Kunder S, Wong J, Doufas AG, Chung F. Obstructive sleep
apnea, pain, and opioids: is the riddle solved? Curr Opin Anaesthe-
siol. 2016;29:134-140.
131. Brown KA, Laferriere A, Moss IR. Recurrent hypoxemia in young
children with obstructive sleep apnea is associated with reduced
opioid requirement for analgesia. Anesthesiology. 2004;100:806-
810. discussion 5A.
132. Brown KA, Laferriere A, Lakheeram I, Moss IR. Recurrent hypox-
emia in children is associated with increased analgesic sensitivity to
opiates. Anesthesiology. 2006;105:665-669.
133. Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J. Acute pain
management: scientific evidence, fourth edition, 2015. Med J Aust.
2016;204:315-317.
134. Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J. Acute pain
management: scientific evidence. APM: SE Working Group of the
Australian and New Zealand College of Anaesthetists and Faculty
of Pain Medicine, Melbourne; 2015. https://fpm.anzca.edu.au/docu
ments/fpm-apmse4-final-20160426-v1-0.pdf. Accessed January 30,
2018.
135. L€onnqvist P-A, Ecoffey C, Bosenberg A, Suresh S, Ivani G. The
European society of regional anesthesia and pain therapy and the
American society of regional anesthesia and pain medicine joint
committee practice advisory on controversial topics in pediatric
regional anesthesia I and II: what do they tell us? Curr Opin Anaes-
thesiol. 2017;30:613-620.
136. Huynh TM, Marret E, Bonnet F. Combination of dexamethasone
and local anaesthetic solution in peripheral nerve blocks. Eur J
Anaesthesiol. 2015;32:1.
137. Shirazi M, Mahmoudi H, Nasihatkon B, Ghaffaripour S, Eslahi A.
Efficacy of dexamethasone on postoperative analgesia in children
undergoing hypospadias repair. Pak J Med Sci. 2016;32:125-129.
138. Messerer B, Grogl G, Stromer W, Jaksch W. Pediatric perioperative
systemic pain therapy: Austrian interdisciplinary recommendations on
pediatric perioperative pain management. Schmerz. 2014;28:43-64.
504 | VITTINGHOFF ET AL.
139. Ecoffey C. Safety in pediatric regional anesthesia. Pediatr Anesth.
2012;22:25-30.
140. Al-Zaben KR, Qudaisat IY, Abu-Halaweh SA, et al. Comparison of
ilioinguinal/iliohypogastric nerve blocks and intravenous morphine
for control of post-orchidopexy pain in pediatric ambulatory sur-
gery. Middle East J Anaesthesiol. 2014;22:393-398.
141. Amminnikutty CM, Karthik A, Kodakkat AK. Postoperative analge-
sia in pediatric herniotomy - Comparison of caudal bupivacaine to
bupivacaine infiltration with diclofenac suppository. Anesth Essays
and Res. 2016;10:250-254.
142. Adamek S, Matouskova O, Pafko P, Slanar O, Perlik F. The role of
diclofenac and piritramide in the management of acute postopera-
tive pain in hernioplasty. Bratisl Lek Listy. 2010;111:616-618.
143. Schnabel A, Reichl SU, Zahn PK, Pogatzki-Zahn E. Nalbuphine for
postoperative pain treatment in children. Cochrane Database Syst
Rev. 2014;7:CD009583.
144. Hong J-Y, Won Han S, Kim WO, Kil HK. Fentanyl sparing effects
of combined ketorolac and acetaminophen for outpatient inguinal
hernia repair in children. J Urol. 2010;183:1551-1555.
145. Weintraud M, Lundblad M, Kettner SC, et al. Ultrasound versus
landmark-based technique for ilioinguinal-iliohypogastric nerve
blockade in children: the implications on plasma levels of ropiva-
caine. Anesth Analg. 2009;108:1488-1492.
146. Sahin L, Sahin M, Gul R, Saricicek V, Isikay N. Ultrasound-guided
transversus abdominis plane block in children: a randomised com-
parison with wound infiltration. Eur J Anaesthesiol. 2013;30:409-
414.
147. Bhalla T, Sawardekar A, Dewhirst E, Jagannathan N, Tobias JD.
Ultrasound-guided trunk and core blocks in infants and children. J
Anesth. 2013;27:109-123.
148. Soh CR, Ng SBA, Lim SL. Dorsal penile nerve block. Pediatr Anesth.
2003;13:329-333.
149. Cyna AM, Middleton P. Caudal epidural block versus other meth-
ods of postoperative pain relief for circumcision in boys. Cochrane
Database Syst Rev. 2008;4:CD003005.
150. O’Sullivan MJ, Mislovic B, Alexander E. Dorsal penile nerve block
for male pediatric circumcision–randomized comparison of ultra-
sound-guided vs anatomical landmark technique. Pediatr Anesth.
2011;21:1214-1218.
151. Qian X, Jin X, Chen L, Pan Y, Wu B, Li J. A new ultrasound-guided
dorsal penile nerve block technique for circumcision in children.
Anaesth Intensive Care. 2015;43:662-663.
152. Kamata M, Cartabuke RS, Tobias JD. Perioperative care of infants
with pyloric stenosis. Pediatr Anesth. 2015;25:1193-1206.
153. Leclair M-D, Plattner V, Mirallie E, et al. Laparoscopic pyloromy-
otomy for hypertrophic pyloric stenosis: a prospective, randomized
controlled trial. J Pediatr Surg. 2007;42:692-698.
154. Yung A, Thung A, Tobias JD. Acetaminophen for analgesia follow-
ing pyloromyotomy: does the route of administration make a differ-
ence? J Pain Res. 2016;9:123-127.
155. Lorenzo AJ, Lynch J, Matava C, El-Beheiry H, Hayes J. Ultrasound
guided transversus abdominis plane vs surgeon administered intra-
operative regional field infiltration with bupivacaine for early post-
operative pain control in children undergoing open pyeloplasty. J
Urol. 2014;192:207-213.
156. Di Pace MR, Cimador M, Catalano P, et al. Efficacy of periportal
infiltration and intraperitoneal instillation of ropivacaine after
laparoscopic surgery in children. J Laparoendosc Adv Surg Tech A.
2009;19:821-825.
157. Lee Z, Schulte M, DeFoor WR, et al. A non-narcotic pathway for
the management of postoperative pain following pediatric robotic
pyeloplasty. J Endourol. 2017;31:255-258.
158. Ben-Meir D, Livne PM, Katz J, Gelman O, Efrat R. Continuous
epidural versus nonepidural analgesia for post-pyeloplasty pain in
children. J Urol. 2009;182:1841-1844.
159. Breschan C, Jost R, Stettner H, et al. Ultrasound-guided rectus
sheath block for pyloromyotomy in infants: a retrospective analysis
of a case series. Pediatr Anesth. 2013;23:1199-1204.
160. Kumar A, Wilson GAM, Engelhardt TE. Ultrasound guided rectus
sheath blockade compared to peri-operative local anesthetic infil-
tration in infants undergoing supraumbilical pyloromyotomy. Saudi J
Anaesth. 2014;8:229-232.
161. Bailie K, Cullen A, Eggleton A. Ultrasound-guided rectus sheath
blocks for open pyloromyotomy: a chance to turn down the gas.
Pediatr Anesth. 2014;24:356-357.
162. Willschke H, B€osenberg A, Marhofer P, et al. Ultrasonography-
guided rectus sheath block in paediatric anaesthesia - a new
approach to an old technique. Br J Anaesth. 2006;97:244-249.
163. F€osel T, F€otsch S, Ebeling O. Postoperative pain therapy after ton-
sillectomy in children. An observational study for 7 days. HNO.
2005;53:722-726.
164. El-Fattah AMA, Ramzy E. Pre-emptive triple analgesia protocol for
tonsillectomy pain control in children: double-blind, randomised,
controlled, clinical trial. J Laryngol Otol. 2013;127:383-391.
165. Park AH, Pappas AL, Fluder E, Creech S, Lugo RA, Hotaling A.
Effect of perioperative administration of ropivacaine with epinephr-
ine on postoperative pediatric adenotonsillectomy recovery. Arch
Otolaryngol Head Neck Surg. 2004;130:459-464.
166. Dahi-Taleghani M, Mousavifard S, Tahmoureszade S, Dabbagh A.
Rectal acetaminophen versus peritonsillar infiltration of bupivacaine
for postoperative analgesia after adenotonsillectomy in children.
Eur Arch Otorhinolaryngol. 2011;268:581-584.
167. Gemma M, Piccioni LO, Gioia L, Beretta L, Bussi M. Ropivacaine
peritonsillar infiltration for analgesia after adenotonsillectomy in
children: a randomized, double-blind, placebo-controlled Study. Ann
Otol Rhinol Laryngol. 2009;118:227-231.
168. Aysenur D, Mine C, Ozgur Y, et al. Pre-emptive peritonsillar dex-
amethasone vs. levobupivacaine infiltration for relief of post-adeno-
tonsillectomy pain in children: a controlled clinical study. Int J
Pediatr Otorhinolaryngol. 2014;78:1467-1471.
169. Ju NY, Cui GX, Gao W. Ropivacaine plus dexamethasone infiltra-
tion reduces postoperative pain after tonsillectomy and adenoidec-
tomy. Int J Pediatr Otorhinolaryngol. 2013;77:1881-1885.
170. Mukherjee K, Esuvaranathan V, Streets C, Johnson A, Carr AS.
Adenotonsillectomy in children: a comparison of morphine and fen-
tanyl for peri-operative analgesia. Anaesthesia. 2001;56:1193-1197.
171. Taheri R, Seyedhejazi M, Ghojazadeh M, Ghabili K, Shayeghi S.
Comparison of ketamine and fentanyl for postoperative pain relief
in children following adenotonsillectomy. Pak J Biol Sci.
2011;14:572-577.
172. He XY, Cao JP, Shi XY, Zhang H. Dexmedetomidine versus mor-
phine or fentanyl in the management of children after tonsillectomy
and adenoidectomy: a meta-analysis of randomized controlled tri-
als. Ann Otol Rhinol Laryngol. 2013;122:114-120.
173. Liu C, Ulualp SO. Outcomes of an alternating ibuprofen and aceta-
minophen regimen for pain relief after tonsillectomy in children.
Ann Otol Rhinol Laryngol. 2015;124:777-781.
174. Aveline C, Le Hetet H, Le Roux A, Bonnet F. A survey of the
administration of prednisolone versus ibuprofen analgesic protocols
after ambulatory tonsillectomy. Anaesth Crit Care Pain Med.
2015;34:281-287.
175. Schnabel A, Reichl SU, Meyer-Frießem C, Zahn PK, Pogatzki-Zahn
E. Tramadol for postoperative pain treatment in children. Cochrane
Database Syst Rev. 2015;3:CD009574.
176. Schug SA. Tramadol in acute pain. Acute Pain. 2003;5:1-2.
177. Antila H, Manner T, Kuurila K, Salanter€A S, Kujala R, Aantaa R.
Ketoprofen and tramadol for analgesia during early recovery after
tonsillectomy in children. Pediatr Anesth. 2006;16:548-553.
178. Sowder JC, Gale CM, Henrichsen JL, et al. Primary caregiver per-
ception of pain control following pediatric adenotonsillectomy: a
VITTINGHOFF ET AL. | 505
cross-sectional survey. Otolaryngol Head Neck Surg. 2016;155:869-
875.
179. Kimiaei Asadi H, Nikooseresht M, Noori L, Behnoud F. The effect
of administration of ketamine and paracetamol versus paracetamol
singly on postoperative pain, nausea and vomiting after pediatric
adenotonsillectomy. Anesth Pain Med. 2016;6:e31210.
180. Merry AF, Edwards KE, Ahmad Z, Barber C, Mahadevan M, Framp-
ton C. Randomized comparison between the combination of aceta-
minophen and ibuprofen and each constituent alone for analgesia
following tonsillectomy in children. Can J Anaesth. 2013;60:1180-
1189.
181. Kokki H, Salonen A, Nikanne E. Perioperative intravenous ketopro-
fen neither prolongs operation time nor delays discharge after ade-
noidectomy in children. Pediatr Anesth. 2001;11:59-64.
182. Chan DK, Parikh SR. Perioperative ketorolac increases post-tonsil-
lectomy hemorrhage in adults but not children. Laryngoscope.
2014;124:1789-1793.
183. Subramanyam R, Varughese A, Kurth CD, Eckman MH. Cost-effec-
tiveness of intravenous acetaminophen for pediatric tonsillectomy.
Pediatr Anesth. 2014;24:467-475.
184. Kubica-Cielinska A, Zielinska M. The use of nalbuphine in paediatric
anaesthesia. Anaesthesiol Intensive Ther. 2015;47:252-256.
185. Schultz-Machata A-M, Becke K, Weiss M. Nalbuphine in pediatric
anesthesia. Anaesthesist. 2014;63:135-143.
186. Wilson C, Sommerfield D, Drake-Brockman TF, von Bieberstein L,
Ramgolam A, von Ungern-Sternberg BS. Pain after discharge fol-
lowing head and neck surgery in children. Pediatr Anesth.
2016;26:992-1001.
187. Voepel-Lewis T, Marinkovic A, Kostrzewa A, Tait AR, Malviya S.
The prevalence of and risk factors for adverse events in children
receiving patient-controlled analgesia by proxy or patient-controlled
analgesia after surgery. Anesth Analg. 2008;107:70-75.
188. Liu Y, Seipel C, Lopez ME, et al. A retrospective study of multi-
modal analgesic treatment after laparoscopic appendectomy in chil-
dren. Pediatr Anesth. 2013;23:1187-1192.
189. Amoli HA, Golozar A, Keshavarzi S, Tavakoli H, Yaghoobi A. Mor-
phine analgesia in patients with acute appendicitis: a randomised
double-blind clinical trial. Emerg Med J. 2008;25:586-589.
190. Wininger SJ, Miller H, Minkowitz HS, et al. A randomized, double-
blind, placebo-controlled, multicenter, repeat-dose study of two
intravenous acetaminophen dosing regimens for the treatment of
pain after abdominal laparoscopic surgery. Clin Ther. 2010;32:2348-
2369.
191. Splinter WM, Thomson ME. Somatic paravertebral block decreases
opioid requirements in children undergoing appendectomy. Can J
Anaesth. 2010;57:206-210.
192. Suresh S, Schaldenbrand K, Wallis B, De Oliveira GS. Regional
anaesthesia to improve pain outcomes in paediatric surgical
patients: a qualitative systematic review of randomized controlled
trials. Br J Anaesth. 2014;113:375-390.
193. Yildiz K, Tercan E, Dogru K, Ozkan U, Boyaci A. Comparison of
patient-controlled analgesia with and without a background infu-
sion after appendicectomy in children. Pediatr Anesth.
2003;13:427-431.
194. Polaner DM, Taenzer AH, Walker BJ, et al. Pediatric regional anes-
thesia network (PRAN): a multi-institutional study of the use and
incidence of complications of pediatric regional anesthesia. Anesth
Analg. 2012;115:1353-1364.
195. Dadure C, Bringuier S, Raux O, et al. Continuous peripheral nerve
blocks for postoperative analgesia in children: feasibility and side
effects in a cohort study of 339 catheters. Can J Anaesth.
2009;56:843-850.
196. Dadure C, Capdevila X. Perioperative analgesia with continuous
peripheral nerve blocks in children. Ann Fr Anesth Reanim.
2007;26:136-144.
197. Messerer B, Platzer M, Justin C, Vittinghoff M. Regional anesthesia
procedures in childhood: Austrian interdisciplinary recommenda-
tions on pediatric perioperative pain management. Schmerz.
2014;28:67-81.
198. Glover CD, Paek JS, Patel N, Manyang P, Mckay SD, Watcha M.
Postoperative pain and the use of ultrasound-guided regional anal-
gesia in pediatric supracondylar humerus fractures. J Pediatr Orthop
B. 2015;24:178-183.
199. Marhofer P, Willschke H, Kettner SC. Ultrasound-guided upper
extremity blocks - tips and tricks to improve the clinical practice.
Pediatr Anesth. 2012;22:65-71.
200. Flack S, Anderson C. Ultrasound guided lower extremity blocks. Pe-
diatr Anesth. 2012;22:72-80.
201. Miller BR. Combined ultrasound-guided femoral and lateral femoral
cutaneous nerve blocks in pediatric patients requiring surgical
repair of femur fractures. Pediatr Anesth. 2011;21:1163-1164.
202. de Jose Marıa B, Banus E, Navarro-Egea M, Banchs RJ. Tips and
tricks to facilitate ultrasound-guided placement of peripheral nerve
catheters in children. Pediatr Anesth. 2011;21:974-979.
203. Southworth S, Peters J, Rock A, Pavliv L. A multicenter, random-
ized, double-blind, placebo- controlled trial of intravenous ibupro-
fen 400 and 800 mg every 6 hours in the management of
postoperative pain. Clin Ther. 2009;31:1922-1935.
How to cite this article: Vittinghoff M, L€onnqvist P-A,
Mossetti V, et al. Postoperative pain management in children:
Guidance from the pain committee of the European Society
for Paediatric Anaesthesiology (ESPA Pain Management
Ladder Initiative). Pediatr Anesth. 2018;28:493–506.
https://doi.org/10.1111/pan.13373
506 | VITTINGHOFF ET AL.
